Ravelcare IPO Details

SME

Ravelcare IPO opens for subscription on 01 Dec 2025 and closes on 03 Dec 2025. The IPO will be listed on BSE with the tentative listing date set for 08 Dec 2025.

Ravelcare IPO price band has been fixed at ₹123 – ₹130 per share.The face value is ₹10 per share with a lot size of 1000.

Ravelcare IPO total issue size comprises 18,54,000 shares (aggregating up to ₹24.10 Cr.). This includes a fresh issue of 18,54,000 shares (aggregating up to ₹24.10 Cr.). Pre-issue shareholding stands at 50,05,000, which will increase to 68,59,000 post-issue.

Ravelcare IPO carries a ₹75 (57.69%) GMP, reflecting investor sentiment.

Ravelcare IPO Lot Size : Individual Minimum is 2 lots (2,000 shares) amounting to ₹260,000. Individual Maximum is 2 lots (2,000 shares) amounting to ₹260,000. SHNI Minimum is 3 lots (3,000 shares) amounting to ₹390,000. SHNI Maximum is 7 lots (7,000 shares) amounting to ₹910,000. BHNI Minimum is 8 lots (8,000 shares) amounting to ₹1,040,000.

The Lead Managers for Ravelcare IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Marwadi Chandarana Intermediaries Brokers Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Ss Corporate Securities. You can analyze their track record by checking the Market Maker Performance Summary report.

For detailed information, Refer to the Ravelcare Limited RHP.

Ravelcare IPO Details

Listing Price : ₹201 at a Premium of 54.62%

Open Date

01 Dec 2025

Close Date

03 Dec 2025

Listing Date

08 Dec 2025

Issue Price

₹123 - ₹130

Face Value

₹10 per share

Lot Size

1000

GMP

₹75 (57.69%)

Issue Type

IPO

Listing On

BSE

Type

Book Built Issue

Share holding pre issue

5005000

Share holding post issue

6859000

Total Issue Size

18,54,000 shares (aggregating up to ₹24.10 Cr.)

Fresh Issue

18,54,000 shares (aggregating up to ₹24.10 Cr.)

Offer for Sale

Ravelcare IPO Subscription

Ravelcare IPO Application Wise Breakup

Ravelcare IPO Dates

01 Dec 2025
Opening dateOpen
03 Dec 2025
Closing dateClose
04 Dec 2025
Allotment Date Allotment
05 Dec 2025
Initiation of RefundsRefund
05 Dec 2025
Credit of SharesCredit
08 Dec 2025
Listing dateListing

Ravelcare IPO Lot Size

Application	Lots	Shares	Amount
Individual Minimum	2	2000	₹260,000
Individual Maximum	2	2000	₹260,000
SHNI Minimum	3	3000	₹390,000
SHNI Maximum	7	7000	₹910,000
BHNI Minimum	8	8000	₹1,040,000

Ravelcare IPO Reservation

Promoter Holding

Pre Issue:99.96%

Post Issue:72.94%

Promoter Names:

Ayush Mahesh Verma

Documents

› Ravelcare IPO DRHP

› Ravelcare IPO RHP

› Anchor Investors in Ravelcare IPO

› Ravelcare IPO BOA

Ravelcare IPO Valuations

ROE:68.04%

ROCE:68.32%

RONW:50.77%

PAT MARGIN:21.01%

PRICE TO BOOK VALUE:6.29

P/E Pre IPO:12.38

P/E Post IPO:13.95

Ravelcare Financial Information

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	15.68	11.63	8.03	1.74
Total Income	14.44	25.30	22.28	3.49
Profit After Tax	3.20	5.26	5.02	0.41
EBITDA	4.33	6.82	6.64	0.51
NET Worth	13.55	10.35	5.10	0.07
Reserves and Surplus	8.54	5.35	5.09	0.07
Total Borrowing			0.04	0.41
Amount in ₹ Crore

About Ravelcare IPO

Incorporated in November 2018, Ravelcare Ltd. is a digital-first beauty and personal care (BPC) brand offering a wide portfolio of haircare, skincare, bodycare, and scalp-care products designed to meet diverse customer requirements.

The company primarily sells its products through its official website and leading online marketplaces, including Amazon, Flipkart, and Myntra, as well as quick-commerce platforms such as Blinkit. During FY 2024–25, Ravelcare expanded its global reach, serving customers in the UAE, Australia, Canada, Germany, the USA, and Saudi Arabia.

To maintain an efficient and dependable supply chain, Ravelcare oversees its logistics and warehousing operations across central Indian states. The company also plans to establish an integrated manufacturing facility in Mauje-Peth, Amravati, Maharashtra, with a proposed installed capacity of 1,050 TPA. This facility is designed to bring R&D, manufacturing, packaging, warehousing, and distribution under a single location, ensuring streamlined operations and faster delivery.

Strength Of Ravelcare IPO

Diversified customer base having a wide geographic presence.
Digital Distribution Channel.
Strong Customer relationships.
Product Innovations.
Consistent track record of growth and financial performance.
Strong technology backbone supported by a dedicated team.

Risk Of Ravelcare IPO

There are certain pending legal proceeding involving Director of the Company. Any adverse outcome on such proceeding may affect its business, financial condition and reputation.
The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect the company business, reputation and results of operations.
The Company has faced losses in the past.
The Company is dependent on few suppliers for purchase of products. Loss of any of these large suppliers may affect its business operations.
The company does not own its Registered Office from where its operations are being conducted and have been taken on lease. Any difficulty in seeking renewal or extension of such lease terms may cause disruption in its operations.
There have been some instances of delay in filing of statutory and regulatory dues in the past with the various government authorities.
The company has historically not complied with Employee State Insurance (ESI) Regulations.
Its dependence on third-party manufacturer for all the company products subjects it to risks, which, if realized, could adversely affect the company business, results of operations, cash flows and financial condition.
The company is significantly dependent on its Website and Digital Media Marketing for the sale of the company products.
The company may be subject to product liability claims from the company customers. Any claims arising from such liabilities may harm its reputation, requires it to incur substantial costs and/or have an adverse impact on the company business, financial conditions and results of operations.